Cystatin C and frailty in older men

Journal of the American Geriatrics Society

Volumn 61, Issue 9, 2013, Pages 1530-1536

  Hart, Allyson ^a   Paudel, Misti L ^b   Taylor, Brent C ^a,b,c   Ishani, Areef ^a,c   Orwoll, Eric S ^d   Cawthon, Peggy M ^e   Ensrud, Kristine E ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Minneapolis Veterans Affairs Health Care System University   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

creatinine; cystatin C; elderly; frailty; kidney function

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; FRAIL ELDERLY; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RACE DIFFERENCE;

CREATININE; CYSTATIN C; ELDERLY; FRAILTY; KIDNEY FUNCTION;

AGED; BIOLOGICAL MARKERS; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FOLLOW-UP STUDIES; FRAIL ELDERLY; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; MALE; NEPHELOMETRY AND TURBIDIMETRY; OSTEOPOROTIC FRACTURES; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; UNITED STATES;

EID: 84884284151     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12413     Document Type: Article

References (30)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
2. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56A: M146-M156.
3. Walston J, Mcburnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-2341.
4. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: Characterization in the Women's Health and Aging Studies. J Gerontol A Biol Sci Med Sci 2006; 61A: 262-266.
5. Boyd CM, Xue QL, Simpson CF, et al. Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med 2005; 118: 1225-1231.
6. Cawthon PM, Marshall LM, Michael Y, et al. Frailty in older men: Prevalence, progression, and relationship with mortality. J Am Geriatr Soc 2007; 55: 1216-1223.
7. Ensrud KE, Ewing SK, Cawthon PM, et al. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 2009; 57: 492-498.
8. Woods NF, LaCroix AZ, Gray SL, et al. Frailty: Emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 2005; 53: 1321-1330.
9. Shlipak MG, Stehman-Breen C, Fried LF, et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 2004; 43: 861-867.
10. Finney H, Bates CJ, Price CP,. Plasma cystatin C determinations in a healthy elderly population. Arch Gerontol Geriatr 1999; 29: 75-94.
11. Wasen E, Isoaho R, Mattila K, et al. Estimation of glomerular filtration rate in the elderly: A comparison of creatinine-based formulae with serum cystatin C. J Intern Med 2004; 256: 70-78.
12. Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008; 3: 348-354.
13. Westhuyzen J,. Cystatin C: A promising marker and predictor of impaired renal function. Ann Clin Lab Sci 2006; 36: 387-394.
14. Fliser D, Ritz E,. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83.
15. Schaeffner ES, Ebert N, Delanaye P, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157: 471-481.
16. Blank JB, Cawthon PM, Carrion-Petersen ML, et al. Overview of recruitment for the Osteoporotic Fractures in Men Study (MrOS). Contemp Clin Trials 2005; 26: 557-568.
17. Orwoll E, Blank JB, Barrett-Connor E, et al. Design and baseline characteristics of the Osteoporotic Fractures in Men (MrOS) Study-a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005; 26: 569-585.
18. Erlandsen EJ, Randers E, Kristensen JH,. Evaluation of the Dade Behring N latex cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 1999; 59: 1-8.
19. Inker LA, Eckfeldt J, Levey AS, et al. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis 2011; 58: 682-684.
20. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406.
21. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
22. Washburn RA, Smith KW, Jette AM, et al. The Physical Activity Scale for the Elderly (PASE): Development and evaluation. J Clin Epidemiol 1993; 46: 153-162.
23. Wilhelm-Leen ER, Hall YN, Tamura K, et al. Frailty and chronic kidney disease: The Third National Health and Nutrition Evaluation Survey. Am J Med 2009; 122: 664-671.
24. Odden MC, Chertow GM, Fried LF, et al. Cystatin C and measures of physical function in elderly adults: The Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol 2006; 164: 1180-1189.
25. Fried LF, Lee JS, Shlipak M, et al. Chronic kidney disease and functional limitation in older people: Health, Aging and Body Composition Study. J Am Geriatr Soc 2006; 54: 750-756.
26. Sarnak MJ, Katz R, Fried LF, et al. Cystatin C and aging success. Arch Intern Med 2008; 168: 147-153.
27. Roshanravan B, Khatri M, Robinson-Cohen C, et al. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 2012; 60: 912-921.
28. Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92.
29. Hamerman D,. Toward an understanding of frailty. Ann Intern Med 1999; 130: 945-950.
30. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009; 75: 652-660. Diseases